HCV remains a significant health threat, with 170 million people being infected and effective therapies for HCV having been elusive. The majority of patients do not resolve the infection and become chronic carriers with increased risk for liver disease. In fact, HCV is the major cause for expensive liver transplantations in the US. There is no vaccine for HCV, and current treatments, which include ribavirin and interferon alpha are expensive and relatively ineffective. Thus, there is a pressing need for new therapeutic intervention. Our preliminary data showed that a conserved region in the viral 5' noncoding region interacts with a liver-specific host-cell microRNA, miR-122, in cultured liver cells. This interaction is essential to maintain intracellular abundance of HCV RNA. In this proposal, we will first examine the requirements and the regulatory components that govern this unprecedented upregulation of HCV RNA by a miR-122. Specifically, we will test the importance of sequences and structures in the target viral and miR-122 RNA in the formation of miR- 122/HCV RNA complexes using a HCV cDNA that can be transcribed to generate replication-competent viral RNA as a tool.
In aim two, the regulatory components of the miR122-RISC complex that interact with the HCV RNA will be examined. In particular, the specific argonaute proteins that reside in miR-122-HCV RISC complexes will be identified. Specifically, we will monitor HCV RNA levels in cells in which individual argonaute mRNAs have been depleted by specific siRNAs and we will examine the presence of HCV RNA in pull-down assays from tagged Ago-RISC complexes. We will also examine whether HCV RNA is cleaved in specific RISC complexes by monitoring whether the viral RNA received nonencoded uridine residues, a signature of the RNAi pathway.
Aim three will delineate the exact steps in the viral life cycle that are affected by miR-122. Specifically, roles for miR-122 in modulating viral RNA stability, translation, replication and virus release will be examined in Northern and polysomal profiling approaches and a novel system in which newly synthesized viral RNAs can be specifically labeled with 4-thiouridine residues. In the final aim, we will study the mechanism by which the cationic amino acid transporter CAT-1 is downregulated by miR-122 and search for additional putative cellular target mRNAs for miR-122 using bioinformatics approaches and a novel strategy by which biotinylated miR-122 can be used as a bait to purify cellular targets. Finally, we will knock-down miR-122 in the rat liver using siRNAs expressed from recombinant adeno-associated viruses and monitor effects on liver function. This approach will reveal whether miR-122 can be used a as a novel antiviral target. The outcomes of these studies will detail a novel mechanism of gene expression in eukaryotic cells and may point to new venues of therapies against HCV. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI069000-01
Application #
7080546
Study Section
Virology - A Study Section (VIRA)
Program Officer
Koshy, Rajen
Project Start
2006-02-15
Project End
2011-01-31
Budget Start
2006-02-15
Budget End
2007-01-31
Support Year
1
Fiscal Year
2006
Total Cost
$309,113
Indirect Cost
Name
Stanford University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Norman, Kara L; Chen, Tzu-Chun; Zeiner, Gusti et al. (2017) Precursor microRNA-122 inhibits synthesis of Insig1 isoform mRNA by modulating polyadenylation site usage. RNA 23:1886-1893
Biegel, Jason M; Henderson, Eric; Cox, Erica M et al. (2017) Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA. Virology 507:231-241
Gonzales-van Horn, Sarah R; Sarnow, Peter (2017) Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses. Cell Host Microbe 21:661-669
Sedano, Cecilia D; Sarnow, Peter (2015) Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells. Semin Liver Dis 35:75-80
Chen, Tzu-Chun; Hsieh, Chung-Han; Sarnow, Peter (2015) Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated Effect. PLoS Pathog 11:e1005116
Sagan, Selena M; Chahal, Jasmin; Sarnow, Peter (2015) cis-Acting RNA elements in the hepatitis C virus RNA genome. Virus Res 206:90-8
Flynn, Ryan A; Martin, Lance; Spitale, Robert C et al. (2015) Dissecting noncoding and pathogen RNA-protein interactomes. RNA 21:135-43
Sedano, Cecilia D; Sarnow, Peter (2014) Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell Host Microbe 16:257-264
Sagan, Selena M; Sarnow, Peter; Wilson, Joyce A (2013) Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction. J Virol 87:7338-47
Cox, Erica Machlin; Sagan, Selena M; Mortimer, Stefanie A W et al. (2013) Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules. RNA 19:1825-32

Showing the most recent 10 out of 17 publications